147 related articles for article (PubMed ID: 28267204)
1. C-terminal truncation of GSK-3β enhances its dephosphorylation by PP2A.
Jin N; Wu Y; Xu W; Gong CX; Iqbal K; Liu F
FEBS Lett; 2017 Apr; 591(7):1053-1063. PubMed ID: 28267204
[TBL] [Abstract][Full Text] [Related]
2. GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner.
Chu D; Tan J; Xie S; Jin N; Yin X; Gong CX; Iqbal K; Liu F
J Alzheimers Dis; 2016; 49(2):365-75. PubMed ID: 26484916
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src.
Yao XQ; Zhang XX; Yin YY; Liu B; Luo DJ; Liu D; Chen NN; Ni ZF; Wang X; Wang Q; Wang JZ; Liu GP
Biochem J; 2011 Jul; 437(2):335-44. PubMed ID: 21554241
[TBL] [Abstract][Full Text] [Related]
4. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
[TBL] [Abstract][Full Text] [Related]
5. Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease.
Jin N; Yin X; Yu D; Cao M; Gong CX; Iqbal K; Ding F; Gu X; Liu F
Sci Rep; 2015 Feb; 5():8187. PubMed ID: 25641096
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of GSK-3β by calpain counteracts the inhibitory effect of Ser9 phosphorylation on GSK-3β activity induced by H₂O₂.
Feng Y; Xia Y; Yu G; Shu X; Ge H; Zeng K; Wang J; Wang X
J Neurochem; 2013 Jul; 126(2):234-42. PubMed ID: 23646926
[TBL] [Abstract][Full Text] [Related]
7. Early glycogen synthase kinase-3β and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathway.
Majd S; Power JH; Koblar SA; Grantham HJ
Eur J Neurosci; 2016 Aug; 44(3):1987-97. PubMed ID: 27177932
[TBL] [Abstract][Full Text] [Related]
8. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta.
Qian W; Shi J; Yin X; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
J Alzheimers Dis; 2010; 19(4):1221-9. PubMed ID: 20308788
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
[TBL] [Abstract][Full Text] [Related]
10. Microcystin-Leucine-Arginine Induces Tau Pathology Through Bα Degradation via Protein Phosphatase 2A Demethylation and Associated Glycogen Synthase Kinase-3β Phosphorylation.
Zhang Y; Zhang J; Wang E; Qian W; Fan Y; Feng Y; Yin H; Li Y; Wang Y; Yuan T
Toxicol Sci; 2018 Apr; 162(2):475-487. PubMed ID: 29228318
[TBL] [Abstract][Full Text] [Related]
11. Cross talk between PI3K-AKT-GSK-3β and PP2A pathways determines tau hyperphosphorylation.
Wang Y; Yang R; Gu J; Yin X; Jin N; Xie S; Wang Y; Chang H; Qian W; Shi J; Iqbal K; Gong CX; Cheng C; Liu F
Neurobiol Aging; 2015 Jan; 36(1):188-200. PubMed ID: 25219467
[TBL] [Abstract][Full Text] [Related]
12. Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer's pathologies?
Manoharan SD; Abdul Hamid H; Md Hashim NF; Cheema MS; Chiroma SM; Mustapha M; Mehat MZ
Brain Res; 2024 Apr; 1829():148793. PubMed ID: 38309553
[TBL] [Abstract][Full Text] [Related]
13. Site-specific phosphorylation protects glycogen synthase kinase-3β from calpain-mediated truncation of its N and C termini.
Ma S; Liu S; Huang Q; Xie B; Lai B; Wang C; Song B; Li M
J Biol Chem; 2012 Jun; 287(27):22521-32. PubMed ID: 22496446
[TBL] [Abstract][Full Text] [Related]
14. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
[TBL] [Abstract][Full Text] [Related]
15. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease.
Bian H; Bian W; Lin X; Ma Z; Chen W; Pu Y
Neurochem Res; 2016 Sep; 41(9):2470-80. PubMed ID: 27255602
[TBL] [Abstract][Full Text] [Related]
16. Membrane depolarization induces the undulating phosphorylation/dephosphorylation of glycogen synthase kinase 3beta, and this dephosphorylation involves protein phosphatases 2A and 2B in SH-SY5Y human neuroblastoma cells.
Lee YI; Seo M; Kim Y; Kim SY; Kang UG; Kim YS; Juhnn YS
J Biol Chem; 2005 Jun; 280(23):22044-52. PubMed ID: 15799972
[TBL] [Abstract][Full Text] [Related]
17. Bip enhanced the association of GSK-3β with tau during ER stress both in vivo and in vitro.
Liu ZC; Fu ZQ; Song J; Zhang JY; Wei YP; Chu J; Han L; Qu N; Wang JZ; Tian Q
J Alzheimers Dis; 2012; 29(4):727-40. PubMed ID: 22460328
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3β regulates leucine-309 demethylation of protein phosphatase-2A via PPMT1 and PME-1.
Yao XQ; Li XC; Zhang XX; Yin YY; Liu B; Luo DJ; Wang Q; Wang JZ; Liu GP
FEBS Lett; 2012 Jul; 586(16):2522-8. PubMed ID: 22732552
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin Alleviates Experimental Diabetic Cardiomyopathy by Regulating the GSK-3β-PP2Ac-NF-κB Signaling Axis.
Ren XM; Zuo GF; Wu W; Luo J; Ye P; Chen SL; Hu ZY
PLoS One; 2016; 11(11):e0166740. PubMed ID: 27851811
[TBL] [Abstract][Full Text] [Related]
20. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]